Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients

被引:27
|
作者
Leu, Wuan-Jin [1 ,2 ]
Liu, Yung-Ching [3 ]
Wang, Hsiao-Wei [3 ]
Chien, Hsiu-Yu [1 ,2 ]
Liu, Hui-Ping [1 ,2 ]
Lin, You-Meei [1 ,2 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pharm, Taipei 23561, Taiwan
[2] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei 23561, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Infect Dis, Taipei 23561, Taiwan
关键词
Vancomycin dosing nomogram; Conventional dosing; Trough concentration; Pharmacokinetic models; MRSA; RESISTANT STAPHYLOCOCCUS-AUREUS; COLONIZATION; PREVALENCE;
D O I
10.1016/j.ijid.2012.07.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The use of a vancomycin dosing nomogram is an alternative and more cost-effective method to conventional dosing; it reliably allows the achievement of trough vancomycin serum concentrations of 5-15 mg/l, with a successful clinical response. Recent guidelines have further recommended that the trough concentration be maintained at 15-20 mg/l for complicated infections. However, to date no published nomogram has been constructed to achieve the optimal trough of 15-20 mg/l in an Asian population. This study aimed to develop two vancomycin nomograms for the achievement of trough concentrations of 5-15 mg/l and 15-20 mg/l in the Taiwanese population, and to ensure the clinical efficacy and safety of such nomograms. Methods: The estimated concentrations and the real concentrations in our patient population were compared between six pharmacokinetic models to see which was the most precise. As the Ambrose method was the best at predicting the trough, this was used to create two nomograms, one for a target trough at 5-15 mg/l and the other for a target trough at 15-20 mg/l. We then evaluated the nomograms by analyzing the number of patients with the target vancomycin trough concentration, clinical and microbiological outcomes, and safety. Results: More patients who had dosing according to the nomogram had a vancomycin trough concentration within the desired target range than patients who had conventional dosing (65.1% vs. 32.1%, p = 0.001). These patients also had a higher rate of 'cure' as the clinical response (35.7% vs. 27.1%) and 'eradication' as the microbiological response (46.4% vs. 29.2%), and a lower rate of nephrotoxicity (14.3% vs. 22.9%). For the patients with a complicated infection, more had a trough between 15 and 20 mg/l when vancomycin was dosed with the nomogram than when dosed conventionally (41.2% vs. 12.1%, p = 0.019). Conclusions: We found that when dosing vancomycin with these nomograms, patients tended to have vancomycin trough concentrations within the target range and also to have a better outcome with regard to clinical efficacy and the safety profile. (C) 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E804 / E810
页数:7
相关论文
共 50 条
  • [1] Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations
    Brown, Matthew L.
    Hutchison, Amber M.
    McAtee, Aaron M.
    Gaillard, Philippe R.
    Childress, Darrell T.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (14) : 1067 - 1075
  • [2] EVALUATION OF VANCOMYCIN DOSING AND CVVH INTENSITY ON VANCOMYCIN TROUGH CONCENTRATIONS ATTAINMENT
    Alhammad, Abdullah
    Reardon, David
    Anger, Kevin
    DeGrado, Jeremy
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [3] Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function
    Ishii, Hidetoshi
    Hirai, Keita
    Sugiyama, Kyohei
    Nakatani, Eiji
    Kimura, Midori
    Itoh, Kunihiko
    [J]. THERAPEUTIC DRUG MONITORING, 2018, 40 (06) : 693 - 698
  • [4] Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15-20 mg/L Suggested by the Vancomycin Consensus Guidelines
    Kullar, Ravina
    Leonard, Steven N.
    Davis, Susan L.
    Delgado, George, Jr.
    Pogue, Jason M.
    Wahby, Krista A.
    Falcione, Bonnie
    Rybak, Michael J.
    [J]. PHARMACOTHERAPY, 2011, 31 (05): : 441 - 448
  • [5] Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration
    Wahby, Krista A.
    Cunmuljaj, Lejla
    Mouabbi, Karim
    Almadrahi, Zinah
    Wilpula, Liz
    [J]. PHARMACOTHERAPY, 2021, 41 (07): : 554 - 561
  • [6] Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
    Neely, Michael N.
    Youn, Gilmer
    Jones, Brenda
    Jelliffe, Roger W.
    Drusano, George L.
    Rodvold, Keith A.
    Lodise, Thomas P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 309 - 316
  • [7] VANCOMYCIN DOSING NOMOGRAM FOR HAEMODIALYSIS PATIENTS
    Jeremiah, Cameron J.
    Wills, Carly
    Bayly, Angela
    Perry, Greg J.
    Davis, Joshua S.
    Tong, Steven Y.
    Currie, Bart J.
    [J]. NEPHROLOGY, 2014, 19 (08) : 513 - 514
  • [8] The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations
    Reilly, Ashley M.
    Ding, Michelle X.
    Rower, Joseph E.
    Kiser, Tyree H.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (07): : 997 - 1005
  • [9] INTERMITTENT DOSING TO ACHIEVE HIGHER VANCOMYCIN TROUGH CONCENTRATIONS IN NEONATES
    Cies, Jeffrey
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (12) : U237 - U237
  • [10] SIMULATION OF VANCOMYCIN PEAK AND TROUGH CONCENTRATIONS USING 5 DOSING METHODS IN 37 PATIENTS
    ZOKUFA, HZ
    RODVOLD, KA
    BLUM, RA
    RIFF, LJ
    FISCHER, JH
    CROSSLEY, KB
    ROTSCHAFER, JC
    [J]. PHARMACOTHERAPY, 1989, 9 (01): : 10 - 16